Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A

Nature Reviews Nephrology

Volumn 7, Issue 8, 2011, Pages 478-484

  Budhiraja, Pooja ^a   Popovtzer, Mordecai ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; THIOPURINE METHYLTRANSFERASE; TRIACYLGLYCEROL LIPASE;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FOLIC ACID BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; GENOTYPE; GLOMERULOPATHY; GRAFT REJECTION; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MALE; PANCREAS BIOPSY; PANCREAS DISEASE; PANCREAS GRAFT REJECTION; PANCYTOPENIA; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; SIDE EFFECT; THROMBOCYTE COUNT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VITAMIN BLOOD LEVEL;

AZATHIOPRINE; ERYTHROCYTE TRANSFUSION; FOLIC ACID; GENOTYPE; GRANULOCYTE COLONY-STIMULATING FACTOR; HOMOZYGOTE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; METHYLTRANSFERASES; MIDDLE AGED; PANCREAS TRANSPLANTATION; PANCYTOPENIA; RECOMBINANT PROTEINS;

EID: 79961030620     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.74     Document Type: Article

References (30)

1. Lennard, L., Gibson, B. E., Nicole, T. & Lilleyman, J. S. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch. Dis. Child. 69, 577-579 (1993). (Pubitemid 23355853)
2. Relling, M. V. et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin. Pharmacol. Ther. 89, 387-391 (2011).
3. Otterness, D. et al. Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms. Clin. Pharmacol. Ther. 62, 60-73 (1997). (Pubitemid 27327100)
4. Lennard, L., Van Loon, J. A., Lilleyman, J. S. & Weinshilboum, R. M. Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin. Pharmacol. Ther. 41, 18-25 (1987). (Pubitemid 17008125)
5. Sandborn, W. J. et al. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology 117, 527-535 (1999). (Pubitemid 29409238)
6. Elion, G. B. The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine. Ann. NY Acad. Sci. 685, 400-407 (1993).
7. Provenzale, D. & Onken, J. E. TPMT genotype screening for patients about to begin azathioprine treatment-a look at costs and potential benefits. Inflamm. Bowel Dis. 11, 1119-1120 (2005). (Pubitemid 41682569)
8. Cheung, S. T. & Allan, R. N. Mistaken identity: Misclassification of TPMT phenotype following blood transfusion. Eur. J. Gastroenterol. Hepatol. 15, 1245-1247 (2003). (Pubitemid 38174852)
9. Yates, C. R. et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 126, 608-614 (1997). (Pubitemid 27172187)
10. Schaeffeler, E. et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14, 407-417 (2004). (Pubitemid 38971231)
11. Langley, P. G., Underhill, J., Tredger, J. M., Norris, S. & McFarlane, I. G. Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J. Hepatol. 37, 441-447 (2002).
12. Evans, W. E. et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J. Clin. Oncol. 19, 2293-2301 (2001). (Pubitemid 32366982)
13. Barlow, N. L., Graham, V. & Berg, J. D. Expressing thiopurine S-methyltransferase activity as units per litre of whole-blood overcomes misleading high results in patients with anaemia. Ann. Clin. Biochem. 47, 408-414 (2010).
14. Yan, L. et al. Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotype correlation analysis. Clin. Pharmacol. Ther. 68, 210-219 (2000). (Pubitemid 30659176)
15. Chocair, P. R., Duley, J. A., Simmonds, H. A. & Cameron, J. S. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53, 1051-1056 (1992).
16. Stocco, G. et al. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin. Pharmacol. Ther. 85, 164-172 (2009).
17. Kurzawski, M., Dziewanowski, K., Lener, A. & Drozdzik, M. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients. Eur. J. Clin. Pharmacol. 65, 533-540 (2009).
18. Chalmers, A. H. Studies on the mechanism of formation of 5-mercapto-1-methyl-4-nitroimidazole, a metabolite of the immunosuppressive drug azathioprine. Biochem. Pharmacol. 23, 1891-1901 (1974).
19. Panetta, J. C., Evans, W. E. & Cheok, M. H. Mechanistic mathematical modelling of mercaptopurine effets on cell cycle of human acute lymphoblastic leukaemia cells. Br. J. Cancer 94, 93-100 (2006). (Pubitemid 43088547)
20. Berns, A., Rubenfeld, S., Rymzo, W. T. Jr. & Calabro, J. J. Hazard of combining allopurinol and thiopurine. N. Engl. J. Med. 286, 730-731 (1972).
21. Qasim, A., Seery, J., Buckley, M. & Morain, C. O. TPMT in the treatment of inflammatory bowel disease with azathioprine. Gut 52, 767 (2003).
22. Dubinsky, M. C. et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118, 705-713 (2000). (Pubitemid 30171620)
23. Osterman, M. T., Kundu, R., Lichtenstein, G. R. & Lewis, J. D. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis. Gastroenterology 130, 1047-1053 (2006).
24. Duley, J. A. & Florin, T. H. Thiopurine therapies: Problems, complexities, and progress with monitoring thioguanine nucleotides. Ther. Drug Monit. 27, 647-654 (2005). (Pubitemid 41437645)
25. Chan, G. L., Erdmann, G. R., Gruber, S. A., Matas, A. J. & Canafax, D. M. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J. Clin. Pharmacol. 30, 358-363 (1990). (Pubitemid 20274115)
26. Schmaldienst, S. et al. Recombinant human granulocyte colony-stimulating factor after kidney transplantation: A retrospective analysis to evaluate the benefit or risk of immunostimulation. Transplantation 69, 527-531 (2000). (Pubitemid 30129584)
27. Scheuermann, T. H., Keeler, C. & Hodsdon, M. E. Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone. Biochemistry 43, 12198-12209 (2004). (Pubitemid 39280563)
28. Karas-Kuzelicki, N., Jazbec, J., Milek, M. & Mlinaric-Rascan, I. Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients. Leukemia 23, 971-974 (2009).
29. Stocco, G. et al. Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. Dig. Dis. Sci. 51, 474-479 (2006).
30. Breen, D. P., Marinaki, A. M., Arenas, M. & Hayes, P. C. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl. 11, 826-833 (2005). (Pubitemid 40975585)